Coppertone, BAY1183345
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Rosacea
Conditions
Rosacea
Trial Timeline
Jan 28, 2019 → Feb 25, 2019
NCT ID
NCT03841032About Coppertone, BAY1183345
Coppertone, BAY1183345 is a pre-clinical stage product being developed by Bayer for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT03841032. Target conditions include Rosacea.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03841032 | Pre-clinical | Completed |
Competing Products
20 competing products in Rosacea